NASDAQ

Inogen, Inc (INGN)

627 Thanks from members

Inogen, Inc. (INGN) exhibits a dual sentiment profile: strong international demand and improving margins counterbalanced by U.S. sales weakness and a reduced full-year revenue outlook, resulting in an ultra-low sales valuation multiple.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →